Initial Trial Of Sanaria's Malaria Vaccine Yields Positive Results
Positive results from the initial Phase 1 clinical trial in 80 healthy volunteers and complementary pre-clinical studies of the Sanaria® PfSPZ Vaccine are published in the online issue of Science. "This is the first indication that a highly effective malaria vaccine may be available that can be used to eliminate Plasmodium falciparum malaria in geographically defined areas and prevent malaria in travelers, " says Fred Binka, MD, PhD, Dean of the School of Public Health, University of Ghana.
Malaria Discovery Gives Hope For New Drugs And Vaccines
An investigation into the mysterious inner workings of the malaria parasite has revealed that it survives and proliferates in the human bloodstream thanks in part to a single, crucial chemical that the parasite produces internally. According to scientists at the University of California, San Francisco (UCSF) and Stanford Medical School, reporting today in the journal PLoS Biology, this insight immediately provides a powerful new tool for discovering and designing drugs to treat malaria, which infects hundreds of millions of people around the world each year and claims more than a million lives mostly children.
Glasgow Scientists Report Major Advance In Sleeping Sickness Drug
A new study published in the open-access journal PLoS Neglected Tropical Diseases on September 6th presents a key advance in developing a safer cure for sleeping sickness. Led by Professor Peter Kennedy, researchers at the University of Glasgow's Institute for Infection, Immunology and Inflammation have created a version of the drug most commonly used to treat sleeping sickness which can be administered orally in pill form. Sleeping sickness - or human African trypanosomiasis (HAT) - is a neglected tropical disease of major importance.